Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN),…
Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth
September 26, 2025 16:05 ET Â | Source: Silynxcom Ltd. Netanya, Israel, Sept.…
UnionPay Expands Acceptance Across Europe, Now Accepted in Over 90% of European Countries and Regions
MADRID, Sept. 26, 2025 /PRNewswire/ -- UnionPay International ("UPI") announced today significant…
Sport highimpact solution to keep people healthy, IOC President Coventry underlines at the UN
26 September 2025 – Sport is one of the “most effective low-cost,…
CLO Launches Marvelous Designer for Linux, Expanding Support for Professional Pipelines
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- CLO Virtual Fashion, a global…
MindHYVE.ai Unveils ChironAI: The World’s First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™…
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ --Â Pictor Holdings Inc., a global leader…
Project InnerSpace Launches GeoFund with First Funded Project to Pioneer Economic Growth Through Sustainable Agriculture
The Tapri India Geothermal Cold Storage Project will boost local incomes, support…
Framatome launches operations in India
MUMBAI, India  , Sept. 22, 2025 /PRNewswire/ -- Framatome inaugurated its India operations base…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…